43 results
8-K
EX-10.1
MACA
Moringa Acquisition Corp
21 Aug 24
Silexion Therapeutics Ltd. and Moringa Acquisition Corp Announce Closing of their Business Combination
4:05pm
Tower, P.O. Box 458, Halifax, Nova Scotia B3J 2P8, Telephone: (902) 424-7768; in Nunavut, Government of Nunavut, Department of Justice, Legal Registries … , Telephone: (306) 787-5879; and in Yukon, Government of Yukon, Department of Community Services, Law Centre, 3rd Floor, 2130 Second Avenue, Whitehorse
8-K
EX-4.1
MACA
Moringa Acquisition Corp
21 Aug 24
Silexion Therapeutics Ltd. and Moringa Acquisition Corp Announce Closing of their Business Combination
4:05pm
& Trust Company 1 State Street, 30th Floor New York, NY 10004 Attn: Compliance Department” 2.13 Currency. A new Section 9.10 is hereby inserted as follows
425
SLXN
Biomotion Sciences Ordinary Shares
25 Jul 24
Business combination disclosure
4:05pm
Cancer Center, Houston, TX Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine Philip A. Philip, MD Henry Ford … The University of Texas & MD Anderson Cancer Center, Houston, TX Department Chair, Department of Surgical Oncology, Division of Surgery and Professor
425
MACA
Moringa Acquisition Corp
25 Jul 24
Business combination disclosure
4:05pm
, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine Philip A. Philip, MD Henry Ford Health, Detroit, MI Director … Cancer Center, Houston, TX Department Chair, Department of Surgical Oncology, Division of Surgery and Professor. Andrew M. Lowy, MD UC San Diego, San Diego
DEFM14A
ilc2kmel7t v083dmm
17 Jul 24
Proxy related to merger
9:13am
8-K
EX-2.1
ivnrt4zj
3 Apr 24
Entry into a Material Definitive Agreement
11:22am
8-K
6iq1 ss98
26 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:29pm
8-K
EX-2.1
obfvoi64
26 Feb 24
Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp
5:29pm
PRER14A
xrp oafecoibl0agd2uf
24 Jul 23
Preliminary revised proxy
4:45pm
8-K
k0jw1
21 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:16pm